- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic ER Her2- Breast Cancer
Total 16415 results
-
Puma Biotechnology, Inc.CompletedHER2 Amplified Breast CancerPortugal
-
Institut Claudius RegaudTerminated
-
Dorte NielsenTerminated
-
Cancer Institute and Hospital, Chinese Academy...First Affiliated Hospital Xi'an Jiaotong University; Wuhan Union Hospital,... and other collaboratorsUnknownHER2-negative Breast CancerChina
-
Seagen Inc.ParexelApproved for marketing
-
Henan Cancer HospitalUnknown
-
Hebei Medical University Fourth HospitalUnknown
-
Western Regional Medical CenterTerminated
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
Novartis PharmaceuticalsRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-negative Early Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
Hoffmann-La RocheActive, not recruiting
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedFemale | HER2-positive Breast CancerRussian Federation
-
Bio-Thera SolutionsUnknownHER2-positive Advanced Breast CancerChina
-
German Breast GroupBoehringer IngelheimCompleted
-
National Cancer Institute (NCI)NRG OncologyRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
Guangdong Provincial People's HospitalSun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Shantou...RecruitingAdvanced Breast Cancer | HER2-negative Breast CancerChina
-
Centre Leon BerardAmgenRecruitingHER2-positive Breast Cancer | Operable Breast CancerFrance
-
AstraZenecaCompleted
-
Herbert LyerlyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | HER2+ Breast CancerUnited States
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerGermany
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
-
Inova Health Care ServicesCity of Hope Medical CenterRecruitingBreast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Jiangxi Provincial Cancer HospitalRecruitingHER2-positive Metastatic Breast CancerChina
-
Centre Oscar LambretRecruitingOvarian Cancer | Hormone-resistant Prostate Cancer | Circulating Tumor Cell | HER2-positive Metastatic Breast CancerFrance
-
Fudan UniversityRecruitingHER2-negative Breast Cancer | Leptomeningeal MetastasisChina
-
Christiana Care Health ServicesCompletedWomen With ER Positive Breast Cancer Taking (AI) w Joint Discomfort and StiffnessUnited States
-
Shanghai Proton and Heavy Ion CenterRecruitingTriple Negative Breast Cancer | HER2-positive Breast CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteThe Shulas' FoundationRecruitingTriple Negative Breast Cancer | HER2-negative Breast CancerUnited States
-
German Breast GroupGilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingTriple Negative Breast Cancer | HER2-negative Breast CancerFrance, Spain, Germany, Switzerland, Austria, Ireland, Belgium
-
Samsung Medical CenterActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
University of NebraskaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2-negative Breast CancerUnited States
-
Fudan UniversityRecruitingHER2 Positive Early Breast CancerChina
-
Zhejiang Cancer HospitalRecruitingHER2-positive Advanced Breast CancerChina
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
Tianjin Medical University Cancer Institute and...CompletedPyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast CancerHER2-positive Advanced Breast CancerChina
-
GlycoMimetics IncorporatedTerminatedBreast Cancer | Breast Cancer Metastatic | HR+ Metastatic Breast CancerUnited States
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Pierre Fabre MedicamentIqvia Pty LtdRecruitingBreast Cancer | HER2-positive Breast Cancer | Adjuvant TherapyBelgium
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruiting
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Breast Diseases | HER2-positive Breast Cancer | Vinorelbine | PyrotinibChina
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom